India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
The basis of overall health, oral health Dental health is now not just a matter of toothache but also a matter of overall body health. For two decades, dental health was focused on solving problems such as toothache, mouth swelling, and toothache. But now it has been proven that it is not just a matter of teeth but also a matter of overall body health. Various studies have found that the first symptoms of about 90 percent of systemic diseases are seen in the mouth. Therefore, dental expertise has now emerged as an important pillar in public health issues. The measures taken to keep the mouth healthy also play an important role in preventing chronic diseases . The mouth is a mirror of the health of our entire body and this is not just a saying but a science. Research says that if there are gum diseases, the risk of heart disease is two to three times higher. Systemic diseases are also interconnected with oral health. Those who neglect oral health are at risk of diseases such as d...